| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/27/2009 | CA2353483C Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 01/27/2009 | CA2315274C Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2225278C Recombinant mva virus, and the use thereof |
| 01/27/2009 | CA2196339C Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 01/27/2009 | CA2186747C Interleukin-15 |
| 01/27/2009 | CA2179825C Method for producing protein |
| 01/27/2009 | CA2173846C Cntf family antagonists |
| 01/27/2009 | CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/25/2009 | CA2597865A1 Compositions for therapeutic treatment of hpv related conditions and diseases |
| 01/22/2009 | WO2009012489A1 Avian influenza chimeric vlps |
| 01/22/2009 | WO2009012173A2 Enhanced biotherapeutic production using inhibitory rna |
| 01/22/2009 | WO2009011259A1 Novel dna fragment, recombinant vector containing the same, transformant transformed therewith and utilization of the same |
| 01/22/2009 | WO2009010042A1 Invention relating to the expression and permanent secretion of canine interleukins |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2008147816A3 Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof |
| 01/22/2009 | WO2006055322A3 High arachidonic acid producing strains of yarrowia lipolytica |
| 01/22/2009 | US20090025100 DWF12 and Mutants Thereof |
| 01/22/2009 | US20090023901 Degradable Clostridial Toxins |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023645 AIB1, a novel steroid receptor co-activator |
| 01/22/2009 | US20090023635 Factor VII or VIIa - Like Molecules |
| 01/22/2009 | US20090023602 Binding polypeptides with restricted diversity sequences |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023186 Use of valproic acid for enhancing production of recombinant proteins in mammalian cells |
| 01/22/2009 | US20090023185 Avidin Mutants |
| 01/22/2009 | US20090023184 Novel Tachykinin Peptides, Precursor Peptides Thereof And Genes Encoding The Same |
| 01/22/2009 | US20090023183 Method For Preparing Recombinant Peptide From Spider Venom and Analgesic Composition Containing The Peptide |
| 01/22/2009 | US20090023162 Method for the identification of atypical p-anca |
| 01/22/2009 | US20090023160 Antibodies specific for CYP1B1 |
| 01/22/2009 | US20090023152 Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 01/22/2009 | US20090023139 Method For Site-Specifically Introducing Non-Natural Amino Acid Into Protien Using Mitochondrial Protein and Method For Effectively Preparing Trna |
| 01/22/2009 | US20090022848 Method of producing liquid koji having enhanced plant fiber degradation enzyme, liquid koji obtained by the method and use thereof |
| 01/22/2009 | US20090022763 Animal product free media and processes for obtaining a botulinum toxin |
| 01/22/2009 | US20090022753 Surface proteins of streptococcus pyogenes |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 01/22/2009 | US20090022747 B7-h3 and b7-h4, novel immunoregulatory molecules |
| 01/22/2009 | US20090022742 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 01/22/2009 | US20090022739 MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR ALPHA (tnf-ALPHA) AND TREATING HUMAN DISEASE OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-ALPHA |
| 01/22/2009 | US20090022738 Multispecific deimmunized CD3-binders |
| 01/22/2009 | US20090022736 Monoclonal Antibodies That Specifically Bind To And Neutralize Bacillus Anthracis Toxin, Compositions, And Methods Of Use |
| 01/22/2009 | US20090022735 Receptor Binding Polypeptides |
| 01/22/2009 | US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022720 Conjugate of an antibody against CD4 and antifusogenic peptides |
| 01/22/2009 | US20090022716 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/22/2009 | US20090022714 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/22/2009 | US20090022710 Nuclear factor of activated t cells receptor |
| 01/22/2009 | US20090022703 Treating age-related macular degeneration associated with a loss of elastic fibers by administering a LOXL1 polypeptide that can catalyze the crosslinking of elastin |
| 01/22/2009 | US20090022702 Methods for introducing mannose 6-phosphate and other oligosacharides onto glycoproteins |
| 01/22/2009 | US20090022659 Antibodies to TNF alpha and use thereof |
| 01/22/2009 | US20090022658 Modified antibodies and methods of use |
| 01/22/2009 | US20090022657 Novel CXCL8 antagonists |
| 01/22/2009 | DE102007033988A1 Producing purified starch comprises grinding cereals containing starch in an air vortex mill to starch flour, separating bran from the flour and subsequently separating proteins from the flour |
| 01/22/2009 | CA2692912A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692826A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692823A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2017286A2 Transporter genes |
| 01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
| 01/21/2009 | EP2016930A2 A cell therapy method for the treatment of tumors |
| 01/21/2009 | EP2016194A2 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 01/21/2009 | EP1836214A4 Compositions, methods, and kits for enhancing protein expression, solubility and isolation |
| 01/21/2009 | EP1831384A4 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 01/21/2009 | EP1774015A4 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
| 01/21/2009 | EP1718753A4 Methods for making and using molecular switches involving circular permutation |
| 01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
| 01/21/2009 | EP1234880B1 Novel protein tab2 |
| 01/21/2009 | CN101351560A Use of b cell expansion agents in generating antibodies |
| 01/21/2009 | CN101351222A Mannose immunogens for HIV-1 |
| 01/21/2009 | CN101348821A High purity sericin powder prepared from silkworm cocoon blaze and preparation thereof |
| 01/21/2009 | CN101348820A High-density fermentation process of recombinant Pichia Pastoris |
| 01/21/2009 | CN101348819A Technology for extracting Chinese yam protain complex by enzyme method |
| 01/21/2009 | CN101348780A Method of isolation and purification of trypsin from pronase protease and use thereof |
| 01/21/2009 | CN101348754A Spirulina extract and preparation thereof |
| 01/20/2009 | USRE40624 An isolated nucleic acid encoding the ASKRK polypeptide comprising an amino acid identification sequence #2; nucleotide sequences; expression vector; pancreatic beta host cell. antidiabetic agents; non-insulin dependent diabetes |
| 01/20/2009 | US7479549 Recombinant canine thyroid stimulating hormone and methods of production and use thereof |
| 01/20/2009 | US7479545 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
| 01/20/2009 | US7479543 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
| 01/20/2009 | US7479542 polymer conjugated drug contains polyethylene glycol covalently attached to the polypeptide; biodrug for treating hepatitis C; new kind of interleukins; fusion proteins |
| 01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
| 01/20/2009 | US7479539 Hedgehog fusion proteins |
| 01/20/2009 | US7479478 Human parathyroid hormone modifications, preparation and use |
| 01/20/2009 | US7479389 Deletions inactivate arginine and histidine biosynthetic pathways in methylotrophic yeast (Pichia pastoris); arginiosuccinate synthase (ARG1); amino-acid N-acetyltransferase (ARG2), ornithine carbamoyltransferase (ARG3), ATP phosphoribosyltransferase (HIS1), histidinol-phosphatase (HIS2) |
| 01/20/2009 | US7479387 Host cell transformed with recombinant enzymes from Arabidopsis thaliana to synthesize 6-sulfo-alpha-D-quinovosyl diaclyglycerol (SQDG) also called sulfoquinovosyldiacylglycerol, KM043 which is a polymerase inhibitor drug; sqdX gene for example |
| 01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 01/20/2009 | US7479384 Nematode MDH-like sequences |
| 01/20/2009 | US7479382 Vectors, host cells; use screening for nematocides; environmentally safe, target-specific ways of controlling plant parasitic nematodes |
| 01/20/2009 | US7479379 Methods for altering protein production rates |
| 01/20/2009 | US7479373 Method for identifying compounds modulating taste transduction |
| 01/20/2009 | US7479372 Beta-secretase substrates and uses thereof |
| 01/20/2009 | US7479284 Babesia canis vaccine |
| 01/20/2009 | US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases |
| 01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
| 01/20/2009 | US7479271 Appetite hormone specific immunoglobulin for prevention and treatment of eating and weight related disorders |
| 01/20/2009 | CA2264570C Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 01/20/2009 | CA2258512C Amidases, nucleic acids encoding them and methods for making and using them |